NCT02111070View on ClinicalTrials.gov

Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy
Interventions
BIOLOGICAL

IL-YANG FLU Vaccine

0.5mL

Trial Locations (1)

Unknown

Seoul St. Mary's Hospital,The Catholic University of Korea, Seoul

All Listed Sponsors
lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT02111070 - Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects | Biotech Hunter | Biotech Hunter